Northwind Pharmaceuticals LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Sep 26, 2025
  • No warning letters matched by name
Inspections 6 1 OAI
Recalls 13 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Northwind Pharmaceuticals LLC has 13 FDA recalls, 6 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Northwind Pharmaceuticals LLC" is on file.

What these totals cover: FDA records filed under the name "Northwind Pharmaceuticals LLC" and its spelling variant "Northwind Pharmaceuticals".

Latest recall
D-0654-2025 · Class II · Aug 20, 2025
Latest inspection
Sep 26, 2025 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls13Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections6Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Northwind Pharmaceuticals LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Northwind Pharmaceuticals LLC: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202510010
202400000
202300070
202200000
202100000
202000000
201900000
201810040
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Northwind Pharmaceuticals LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Northwind Pharmaceuticals LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

13 recall records from Nov 10, 2015 to Aug 20, 2025.

NumberClassProductDate
D-0654-2025Class IISulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count…Aug 20, 2025
D-0548-2023Class IIAtorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind…Mar 16, 2023
D-0550-2023Class IIDoxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals…Mar 16, 2023
D-0553-2023Class IITadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count…Mar 16, 2023
D-0551-2023Class IIGlimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count…Mar 16, 2023
D-0549-2023Class IIBusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind…Mar 16, 2023
D-0552-2023Class IIGlimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count…Mar 16, 2023
D-0554-2023Class IITadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals…Mar 16, 2023
D-1097-2018Class IIValsartan, 80mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals…Jul 18, 2018
D-1098-2018Class IIValsartan, 320mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals…Jul 18, 2018
D-1096-2018Class IIValsartan HCTZ, 160/12.5mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind…Jul 18, 2018
D-1095-2018Class IIValsartan, 160 mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals…Jul 18, 2018
D-0485-2016Class IIIPrednisone 20 mg, Tablet, 10-count bottle, Rx only, Mfg by: HIKMA Pharmaceuticals PO BOX 182400…Nov 10, 2015

Recent FDA inspections

6 inspections from Oct 14, 2014 to Sep 26, 2025.

DateSiteProductClassificationFEI
Sep 26, 2025Indianapolis, INDrugsVoluntary Action Indicated (VAI)1831143
Nov 16, 2018Indianapolis, INDrugsVoluntary Action Indicated (VAI)1831143
Mar 13, 2017Indianapolis, INDrugsNo Action Indicated (NAI)1831143
Dec 9, 2015Indianapolis, INDrugsOfficial Action Indicated (OAI)1831143
Sep 14, 2015Indianapolis, INDrugsVoluntary Action Indicated (VAI)1831143
Oct 14, 2014Indianapolis, INDrugsNo Action Indicated (NAI)1831143
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1831143Indianapolis, IN6Sep 26, 2025

Northwind Pharmaceuticals LLC and the FDA: common questions

Has Northwind Pharmaceuticals LLC received an FDA warning letter?

No FDA warning letter addressed to the name "Northwind Pharmaceuticals LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Northwind Pharmaceuticals LLC received an FDA Form 483?

FDA has not published a Form 483 for "Northwind Pharmaceuticals LLC" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Northwind Pharmaceuticals LLC?

The most recent FDA inspection on file ended Sep 26, 2025 at Indianapolis, IN and was classified VAI. FDA has 6 inspections of Northwind Pharmaceuticals LLC on file, 1 of them classified OAI (official action indicated).

Has Northwind Pharmaceuticals LLC had an FDA recall?

Yes. Northwind Pharmaceuticals LLC has 13 FDA recalls on record. The most recent started Aug 20, 2025.

Need more than this page shows? Ask about Northwind Pharmaceuticals LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.